We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.13% |
| 2 | Technology | 18.75% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMX
276
DELISTED
Terminix Global Holdings, Inc.
TMX
| $34.2M | 0.08% |
959,008
-240,455
| -20% | -$7.41M |
|
277
Markel Group
MKL
$25.2B
| $34.1M | 0.08% |
36,944
+18
| +0% | +$16.4K |
|
278
Chubb
CB
$140B
| $33.9M | 0.08% |
267,958
-54,347
| -17% | -$6.3M |
|
|
CFRX
279
DELISTED
ContraFect Corporation
CFRX
| $33.8M | 0.08% |
66,215
+28,090
| +74% | +$13.8M |
|
|
ABMD
280
DELISTED
Abiomed Inc
ABMD
| $33.6M | 0.08% |
139,210
-31,599
| -18% | -$6.34M |
|
281
General Mills
GIS
$20.2B
| $33.5M | 0.08% |
543,994
-114,686
| -17% | -$6.92M |
|
282
Moelis & Co
MC
$4.85B
| $33.2M | 0.08% |
1,065,000
+175,000
| +20% | +$5.49M |
|
283
Linde
LIN
$236B
| $33M | 0.08% |
155,662
+42,643
| +38% | +$8.23M |
|
284
BlackLine
BL
$1.9B
| $33M | 0.08% |
397,500
+97,455
| +32% | +$6.51M |
|
285
Baidu
BIDU
$35.7B
| $32.5M | 0.08% |
270,869
-286,578
| -51% | -$30.7M |
|
286
Community Bank
CBU
$3.39B
| $32.5M | 0.08% |
569,318
-354,852
| -38% | -$20.9M |
|
287
Lowe's Companies
LOW
$121B
| $32.4M | 0.08% |
239,703
+91,938
| +62% | +$10.5M |
|
288
Inspire Medical Systems
INSP
$1.47B
| $32.3M | 0.08% |
371,120
+37,620
| +11% | +$2.89M |
|
289
Cooper Companies
COO
$14.2B
| $31.9M | 0.08% |
449,800
-92,372
| -17% | -$6.85M |
|
290
NeoGenomics
NEO
$1.99B
| $31.8M | 0.08% |
1,026,177
-126,837
| -11% | -$3.51M |
|
291
AnaptysBio
ANAB
$1.54B
| $31.6M | 0.08% |
1,415,310
+141,543
| +11% | +$2.59M |
|
292
Korro Bio
KRRO
$145M
| $31.6M | 0.08% |
27,178
-1,157
| -4% | -$1.05M |
|
293
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
| $31M | 0.08% |
715,000
+625,000
| +694% | +$26.5M |
|
294
Intercontinental Exchange
ICE
$87.2B
| $30.9M | 0.08% |
337,398
+315,235
| +1,422% | +$28.9M |
|
295
Ingersoll Rand
IR
$33.1B
| $30.9M | 0.08% |
1,098,677
+589,365
| +116% | +$16.6M |
|
296
FIVE9
FIVN
$2.08B
| $30.4M | 0.08% |
274,703
-83,015
| -23% | -$8.08M |
|
297
PTC
PTC
$15.3B
| $30.4M | 0.08% |
390,204
-92,866
| -19% | -$6.58M |
|
298
CBRE Group
CBRE
$43.3B
| $30.3M | 0.08% |
670,579
-306,548
| -31% | -$13.2M |
|
299
CryoPort
CYRX
$753M
| $30.3M | 0.07% |
1,000,000
| – | – |
|
300
Intuitive Surgical
ISRG
$127B
| $30M | 0.07% |
158,028
-25,116
| -14% | -$4.5M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.